Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Hiroyuki Hanayama
Fukushima Medical University
Hikari-gaoka 1
Fukushima, 960-1295
Japan
Contact
Fukushima Medical University
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
29
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Nivolumab in Combination with Radiotherapy for Unresectable Advanced or Recurrent Gastric Cancer (Circuit Trial): A 3-Year Update of the Progression-Free Survival and Local Control Outcomes
Number of pages: 24
Posted: 07 Aug 2025
Yoshiyuki Suzuki
,
Daisaku Yoshida
,
Kosaku Mimura
,
Takashi Ogata
,
Yuya Yoshimoto
,
Hiroyuki Katoh
, Hiroyuki Hanayama,
Nozomu Machida
,
Hisashi Sato
,
Zenichiro Saze
,
Takanobu Yamada
,
Yasuhiro Inokuchi
,
Fumiaki Takahashi
,
Takashi Oshima
and
Koji Kono
Fukushima Medical University, Kanagawa Cancer Center, Fukushima Medical University, Kanagawa Cancer Center - Department of Gastrointestinal Surgery, Fukushima Medical University, Kanagawa Cancer Center, Fukushima Medical University, Kanagawa Cancer Center, Fukushima Medical University, Fukushima Medical University, Kanagawa Cancer Center, Kanagawa Cancer Center, Iwate Medical University, Kanagawa Cancer Center and Fukushima Medical University - Department of Gastrointestinal Tract Surgery
Downloads
29
(1,332,057)
View PDF
Download
Abstract:
Gastric cancer, nivolumab
Feedback
